Sol-Gel Technologies Announces Last Patient Last Visit In Pivotal Phase 3 Trial Of SGT-610 For Gorlin Syndrome; Says Top-Line Results On Track For Late November

뉴스 본문을 불러오고 있어요.

Sol-Gel Technologies Announces Last Patient Last Visit In Pivotal Phase 3 Trial Of SGT-610 For Gorlin Syndrome; Says Top-Line Results On Track For Late November | 웨이프 WAPE

Sol-Gel Technologies Announces Last Patient Last Visit In Pivotal Phase 3 Trial Of SGT-610 For Gorlin Syndrome; Says Top-Line Results On Track For Late November

기사 요약

관련 종목

댓글 —